Stryker expects the robot, called Mako RPS, to bring in new customers, including more ambulatory surgery centers.

CEO Kevin Lobo described 2025 as “outstanding for both Q4 and the full year across all key financial metrics,” with organic sales growth of 11% in Q4 and 10.3% for the year, surpassing $25 billion in ...

Stryker introduces new Foot & Ankle products, including the Ankle Truss and Osteotomy Truss Systems, enhancing their surgical portfolio. Analysts maintain positive outlooks for Stryker with high price ...

Since completing the $4.9bn acquisition of Inari Medical in February 2025, Stryker's biggest growth area was in its vascular ...

Stryker reported an adjusted fourth-quarter earnings per share (EPS) of $4.47, beating analysts' consensus of $4.40.